NORTHERN SYDNEY AND CENTRAL CO has a total of 19 patent applications. Its first patent ever was published in 1997. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ONYX PHARMACEUTICALS, T2CURE GMBH and FUWAN PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Agriculture | |
#6 | Mechanical elements | |
#7 | Furniture and games |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Animal care | |
#7 | Physical therapy devices | |
#8 | Physical training equipment | |
#9 | Syringes | |
#10 | Frames |
# | Name | Total Patents |
---|---|---|
#1 | O'Neill Christopher | 6 |
#2 | Rasmussen Helge H | 2 |
#3 | Jackson Christopher John | 2 |
#4 | Bundgaard Henning | 2 |
#5 | Xue Meilang | 2 |
#6 | Manolios Nicholas | 2 |
#7 | Morris Jonathan M | 1 |
#8 | Wallace Gordon G | 1 |
#9 | O'Sullivan Maree | 1 |
#10 | Robinson Bruce | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008098306A1 | Iv stand hanger assembly | |
WO2009043080A1 | Apparatus and method for assessment of susceptibility to conditions having a craniofacial morphological relationship | |
WO2008031165A1 | Methods and compositions for the diagnosis and treatment of tumours | |
WO2007124529A1 | Modulation of t helper cell-mediated immune responses | |
AU2007201764A1 | Methods for assessing embryo viability | |
US2007254309A1 | Methods for Assessing Embryo Viability | |
WO2006110940A1 | Biomarker for growth hormone | |
EP1841442A1 | Treatment for autoimmune and inflammatory conditions | |
CN1946389A | Methods and compositions for the treatment of myocardial conditions | |
AU2004267115A1 | Methods for enhancing embryo viability | |
EP2009018A2 | T cell antigen receptor peptides |